Our Media - Meet our experts: Pediatrics

There is a demand to develop new drug therapies for pediatric indications. As children cannot merely be seen as small adults, proper dose selection for pediatric programs may require special attention. Meet Mats Magnusson and Siv Jönsson, sharing their experiences about supporting clients with the planning, implementation, and reporting of drug development programs in pediatric populations.